These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2042667)

  • 41. VetCompanion: response and clarifications.
    Mauer MP; Garcia J
    J Med Libr Assoc; 2017 Jul; 105(3):293-294. PubMed ID: 28670221
    [No Abstract]   [Full Text] [Related]  

  • 42. A few clarifications on MIRIBEL.
    Faria M; Björnmalm M; Crampin EJ; Caruso F
    Nat Nanotechnol; 2020 Jan; 15(1):2-3. PubMed ID: 31925392
    [No Abstract]   [Full Text] [Related]  

  • 43. Clarifications in Abstract and Key Points.
    JAMA Psychiatry; 2018 Jul; 75(7):759. PubMed ID: 29971371
    [No Abstract]   [Full Text] [Related]  

  • 44. Clarifications of Terms and for Interpreting Incidence Rate Ratios.
    JAMA Pediatr; 2021 May; 175(5):538. PubMed ID: 33683345
    [No Abstract]   [Full Text] [Related]  

  • 45. Incorrect Expansion of a Term and Other Clarifications.
    JAMA; 2018 Sep; 320(11):1202. PubMed ID: 30422281
    [No Abstract]   [Full Text] [Related]  

  • 46. RECALCAR methodology. Some clarifications.
    Cequier Á; Bernal JL; Fernández Pérez C; Elola FJ
    Rev Esp Cardiol (Engl Ed); 2023 Jan; 76(1):74-75. PubMed ID: 36108996
    [No Abstract]   [Full Text] [Related]  

  • 47. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clarifications to Pediatric Drug Formulations.
    Walsh K
    Am J Hosp Pharm; 1991 Apr; 48(4):682. PubMed ID: 2042667
    [No Abstract]   [Full Text] [Related]  

  • 50. Extemporaneous drug formulations.
    Nahata MC; Allen LV
    Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Roll compaction/dry granulation: pharmaceutical applications.
    Kleinebudde P
    Eur J Pharm Biopharm; 2004 Sep; 58(2):317-26. PubMed ID: 15296958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanosizing--oral formulation development and biopharmaceutical evaluation.
    Kesisoglou F; Panmai S; Wu Y
    Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.